Results 161 to 170 of about 7,433 (204)

Allergic bronchopulmonary aspergillosis [PDF]

open access: yesAllergy: European Journal of Allergy and Clinical Immunology, 2005
Allergic bronchopulmonary aspergillosis (ABPA) is an immunologically mediated lung disease which occurs predominantly in patients with asthma, and is caused by hypersensitivity to colonized Aspergillus fumigatus. It is a chronic, relapsing disorder which can clinically range from mild asthma to fibrotic lung disease.
A -B Tonnel
exaly   +5 more sources

Allergic Bronchopulmonary Aspergillosis

Chest, 2009
Allergic bronchopulmonary aspergillosis (ABPA) is not a common condition, even though asthma due to sensitization to Aspergillus antigen is very common in many countries because of the ubiquitous distribution of the fungus itself. During the course of 14 years, the Mycology Department of the V. P.
Ritesh Agarwal
exaly   +5 more sources

Allergic bronchopulmonary aspergillosis

Journal of Allergy and Clinical Immunology, 1984
Allergic bronchopulmonary aspergillosis (ABPA) complicates asthma and cystic fibrosis. The survival factors in Aspergillus fumigatus that support saprophytic growth in bronchial mucus are not understood. Prednisone remains the most definitive treatment but need not be administered indefinitely.
A J, Ricketti   +3 more
openaire   +6 more sources

Allergic Bronchopulmonary Aspergillosis

Clinics in Chest Medicine, 2022
Allergic bronchopulmonary aspergillosis (ABPA) is a complex allergic disorder caused by immune reactions against Aspergillus fumigatus. ABPA most commonly complicates the course of patients with poorly controlled asthma. Patients commonly present with uncontrolled asthma, fleeting pulmonary opacities, and bronchiectasis.
Ritesh Agarwal   +2 more
exaly   +3 more sources

Allergic Bronchopulmonary Aspergillosis

Archives of Internal Medicine, 1985
Allergic bronchopulmonary aspergillosis (ABPA) occurs as a complication of asthma. It presents as an infiltrative pulmonary disorder with respiratory and systemic symptoms, eosinophilia, elevated total serum IgE, and skin sensitizing, as well as precipitating antibodies to Aspergillus fumigatus. Sputum cultures are not always positive for the organism.
openaire   +5 more sources

Allergic Bronchopulmonary Aspergillosis

Clinics in Chest Medicine, 2012
Allergic bronchopulmonary aspergillosis (ABPA) is caused by an exaggerated T(H)2 response to the ubiquitous mold Aspergillus fumigatus. ABPA develops in a small fraction of patients with cystic fibrosis and asthma, suggesting that intrinsic host defects play a major role in disease susceptibility.
Sonia N, Bains, Marc A, Judson
openaire   +2 more sources

Allergic Bronchopulmonary Aspergillosis

Annual Review of Medicine, 1999
Allergic bronchopulmonary aspergillosis (ABPA) is a syndrome seen in patients with asthma and cystic fibrosis. It is characterized by chronic colonization of the airways with a ubiquitous fungus, Aspergillus fumigatus. The clinical expression of ABPA results from the complex interaction of chronic colonization of the airways with A.
B A, Cockrill, C A, Hales
openaire   +2 more sources

Allergic Bronchopulmonary Aspergillosis

Proceedings of the American Thoracic Society, 2010
Abstract Allergic bronchopulmonary aspergillosis (ABPA) is a complex clinical entity that results from an allergic immune response to Aspergillus fumigatus, most often occurring in a patient with asthma or cystic fibrosis. Sensitization to aspergillus in the allergic host leads to activation of T helper 2 lymphocytes, which play a key
Karen, Patterson, Mary E, Strek
openaire   +2 more sources

Allergic Bronchopulmonary Aspergillosis

Seminars in Respiratory and Critical Care Medicine, 2006
Allergic bronchopulmonary aspergillosis is an uncommon but serious respiratory condition characterized by chronic airway inflammation and airway damage resulting from persistent colonization by and sensitization to the fungus Aspergillus fumigatus. The immunopathogenesis of allergic bronchopulmonary aspergillosis involves several pathways.
openaire   +2 more sources

Allergic Bronchopulmonary Aspergillosis with Adenopathy

Annals of Internal Medicine, 1991
Excerpt Allergic bronchopulmonary aspergillosis, first described by Hinson and associates (1) in 1952, is a hypersensitivity reaction to the fungusAspergillus.
C E, Hantsch, T, Tanus
openaire   +2 more sources

Home - About - Disclaimer - Privacy